Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch

Clinical Transplantation ◽

10.1111/ctr.12913 ◽

2017 ◽

Vol 31 (4) ◽

pp. e12913 ◽

Author(s):

Gil Cunha De Santis ◽

Aline Cristina Garcia-Silva ◽

Giuliana Martinelli Dotoli ◽

Pamela Tinti de Castro ◽

Belinda Pinto Simões ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Red Blood Cell Transfusion ◽

Transfusion Requirements

Download Full-text

Faculty Opinions recommendation of Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969540.793470452 ◽

2013 ◽

Author(s):

Neyssa Marina ◽

Maureen O'Brien

Keyword(s):

Clinical Trial ◽

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Marrow Transplant ◽

Red Blood Cell Transfusion ◽

Blood And Marrow Transplant ◽

Download Full-text

Faculty Opinions recommendation of Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969540.793468997 ◽

2013 ◽

Author(s):

Nelson Chao ◽

John Chute

Keyword(s):

Clinical Trial ◽

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Marrow Transplant ◽

Red Blood Cell Transfusion ◽

Blood And Marrow Transplant ◽

Download Full-text

Excess of Veno-Occlusive Disease in a Randomized Clinical Trial on a Higher Trigger for Red Blood Cell Transfusion after Bone Marrow Transplantation: A Canadian Blood and Marrow Transplant Group Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2012.12.002 ◽

2013 ◽

Vol 19 (3) ◽

pp. 468-473 ◽

Author(s):

Nancy Robitaille ◽

Jacques Lacroix ◽

Lubomir Alexandrov ◽

Lucy Clayton ◽

Marion Cortier ◽

...

Keyword(s):

Clinical Trial ◽

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Marrow Transplant ◽

Red Blood Cell Transfusion ◽

Blood And Marrow Transplant ◽

Download Full-text

Use of the Gel Test to Detect Mixed Red Blood Cell Populations in Bone Marrow Transplantation Patients

Vox Sanguinis ◽

10.1111/j.1423-0410.1993.tb02138.x ◽

1993 ◽

Vol 65 (2) ◽

pp. 161-162 ◽

Author(s):

M. C. Zago-Novaretti ◽

F. L. Dulley ◽

P. E. Dorlhiac-Lacer ◽

D. A. F. Chamone

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Cell Populations

Download Full-text

RECOVERY OF HEMATOPOIESIS AFTER BLOOD-GROUP-INCOMPATIBLE BONE MARROW TRANSPLANTATION WITH RED-BLOOD-CELL-DEPLETED GRAFTS

Transplantation Journal ◽

10.1097/00007890-198505000-00011 ◽

1985 ◽

Vol 39 (5) ◽

pp. 514-519 ◽

Author(s):

J. H. F. FALKENBURG ◽

M. R. SCHAAFSMA ◽

J. JANSEN ◽

A. BRAND ◽

H. M. GOSELINK ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Blood Group ◽

Red Blood Cell ◽

Marrow Transplantation

Download Full-text

A Simple Technique for Red Blood Cell Removal in Major ABO-Incompatible Bone Marrow Transplantation

Vox Sanguinis ◽

10.1111/j.1423-0410.1994.tb00291.x ◽

1994 ◽

Vol 66 (2) ◽

pp. 112-116 ◽

Author(s):

Gerhard Mayer ◽

Dorothee Wernet ◽

Hinnak Northoff ◽

Werther Schneider

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Simple Technique

Download Full-text

Multiple red blood cell antibodies produced by donor B lymphocytes after ABO-matched allogeneic bone marrow transplantation

Transfusion Science ◽

10.1016/s0955-3886(99)00020-x ◽

1999 ◽

Vol 20 (2) ◽

pp. 121-127 ◽

Author(s):

Tetsunori Tasaki ◽

Sakiko Sasaki ◽

Kenji Gotoh ◽

Chuichi Itoh ◽

Shigeki Itoh ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

B Lymphocytes ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Allogeneic Bone Marrow Transplantation ◽

Allogeneic Bone Marrow ◽

Allogeneic Bone

Download Full-text

ABO-incompatible bone marrow transplantation: Three methods for the removal of red blood cell antibodies

Plasma Therapy and Transfusion Technology ◽

10.1016/s0278-6222(87)80043-8 ◽

1987 ◽

Vol 8 (4) ◽

pp. 355-359 ◽

Author(s):

A. Tichelli ◽

A. Gratwohl ◽

C. Nissen ◽

A. Lori ◽

A. Würsch ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation

Download Full-text

Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs

Blood ◽

10.1182/blood.v83.7.1952.1952 ◽

1994 ◽

Vol 83 (7) ◽

pp. 1952-1957 ◽

Author(s):

AJ Mitus ◽

JH Antin ◽

CJ Rutherford ◽

CJ McGarigle ◽

MA Goldberg

Keyword(s):

Bone Marrow ◽

Red Blood Cell ◽

Recombinant Human Erythropoietin ◽

Allogeneic Bone Marrow Transplantation ◽

Allogeneic Bone Marrow ◽

Red Blood Cell Transfusion ◽

Allogeneic Bone ◽

Human Erythropoietin ◽

Transfusion Requirements

Abstract In an attempt to reduce or eliminate homologous red blood cell transfusion requirements during allogeneic bone marrow transplantation (BMT), we instituted a novel program whereby recombinant human erythropoietin was administered to pairs of BMT donors and recipients. Eleven recipients and their HLA-matched donors were enrolled. Donors treated with recombinant human erythropoietin (rHuEPO) were phlebotomized a median of 6 U (range, 4 to 11 U) of blood over a 5-week period. This donor-derived blood was available to the BMT donor or recipient as needed. Transplant recipients were also treated with rHuEPO post-BMT to hasten erythropoiesis. Five of 11 BMT recipients underwent transplant receiving only donor-derived red blood cell transfusion, compared with 0 of 11 concomitant control recipients (P = .04). In addition, the time to absolute reticulocyte count > or = 10(4)/microL was statistically shorter in the rHuEPO-treated recipient group. This study serves as a paradigm for hematopoietic growth factor use in allogeneic BMT to decrease or eliminate homologous transfusion exposures and to possibly hasten hematopoietic engraftment.

Download Full-text

Flow cytometry analysis of dual red blood cell populations after bone marrow transplantation

British Journal of Haematology ◽

10.1111/j.1365-2141.1995.tb08410.x ◽

2008 ◽

Vol 89 (4) ◽

pp. 741-747 ◽

Author(s):

D. Blanchard ◽

V. Bruneau ◽

F. Germond-Arnoult ◽

D. Bernard ◽

A. Gourbil ◽

...

Keyword(s):

Bone Marrow ◽

Flow Cytometry ◽

Bone Marrow Transplantation ◽

Red Blood Cell ◽

Marrow Transplantation ◽

Cell Populations ◽

Flow Cytometry Analysis

Download Full-text